Analysis of efficacy and safety of interferon-free therapy for recurrent hepatitis C after liver transplantation

Analysis of efficacy and safety of interferon-free therapy for recurrent hepatitis C after liver transplantation - Interferon-free therapy for posttransplant hepatitis C

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000018759

Enrollment

Registered

2015-09-01

Start date

2015-09-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatitis C after liver transplantation

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Recurrent hepatitis C after liver transplantation 2. Chronic hepatitis or compensated liver cirrhosis 3. 20 years old and over 4. Written informed concent for participation in this study is obtained

Exclusion criteria

Exclusion criteria: Patients without ability to understand the informed concent

Design outcomes

Primary

Measure	Time frame
Efficacy and safety of interferon-free therapy for recurrent hepatitis C after liver transplantation	—

Secondary

Measure	Time frame
1. Impact on quality of life in intervention with interferon-free treatment 2. Drug-drug interactions	—

Countries

Japan

Contacts

Public ContactYoshihide Ueda

Kyoto University Hospital Gastroenterology and Hepatology

yueda@kuhp.kyoto-u.ac.jp81-75-751-4319

Outcome results